Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dioko Ventures is a private healthcare-focused venture capital firm that invests in early-stage and growth-stage companies rather than developing therapeutics itself. The firm has been described as focusing on healthcare services, healthcare information technology, software, and software-enabled services that improve how care is delivered. Its first fund, Dioko Health Ventures I, L.P., closed in 2018 with approximately $17 million of committed capital. Reported portfolio companies and investments have included businesses such as RubiconMD, SonderMind, Feedtrail, Healthy Bytes, and Novarus Healthcare. The firm appears to operate as an active private investment manager in the healthcare ecosystem rather than as a biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dioko Health Ventures.